Guided Therapeutics Inc. announced the appointment of Gene Cartwright as Chief Executive Officer, effective January 6, 2014. Mr. Cartwright replaces Mark L. Faupel, who has transitioned to the role of Chief Scientific Officer. Gene Cartwright joins Guided Therapeutics from Omnyx, LLC, where, as CEO for over 4 years he founded and managed the successful development of products for the field of Digital Pathology.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 USD | 0.00% | -8.26% | -34.85% |
1st Jan change | Capi. | |
---|---|---|
-34.85% | 5.57M | |
+7.32% | 217B | |
+13.83% | 195B | |
+20.48% | 144B | |
+31.33% | 112B | |
+3.08% | 65.83B | |
+14.64% | 52.67B | |
+2.72% | 49.86B | |
-5.88% | 38.18B | |
+0.25% | 35.39B |
- Stock Market
- Equities
- GTHP Stock
- News Guided Therapeutics, Inc.
- Guided Therapeutics, Inc Announces Executive Changes